News
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
2h
News-Medical.Net on MSNSingle-cell sequencing maps immune changes in chronic myeloid leukemiaZhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...
In a discovery that could reshape approaches to regenerative medicine and bone repair, researchers have found that human stem ...
Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...
Antonio Jimenez Jimenez, MD, discusses the ACCESS study using HLA-mismatched unrelated donors for peripheral blood and bone ...
Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...
1d
News Medical on MSNStem cells transform into bone cells by squeezing through narrow spacesIn a discovery that could reshape approaches to regenerative medicine and bone repair, researchers have found that human stem cells can be prompted to begin turning into bone cells simply by squeezing ...
In the beginning, when I was very young, I was more interested in acute leukaemia and the suffering of young people. When I ...
Bone marrow microenvironment in prostate cancer Maria Chiara Masone Research Highlights 05 Nov 2021 Nature Reviews Urology Volume: 18, P: 706 All News & Comment ...
The status has been given to the B7-H3-targeted drug as a treatment for late-line relapsed or refractory osteosarcoma, a rare form of bone cancer with no FDA-approved treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results